Cargando…
Standard Treatment Remains the Recommended Approach for Patients with Bone Sarcoma Who Underwent Unplanned Surgery: Report from the Japanese Musculoskeletal Oncology Group
BACKGROUND: The outcomes of unplanned surgery for bone sarcomas have not been frequently discussed. However, it is important to recognize patterns, treatment, and clinical outcomes of unplanned surgeries for patients with bone sarcomas. This multicenter study aimed to characterize the clinical outco...
Autores principales: | Nakamura, Tomoki, Sugaya, Jun, Naka, Norifumi, Kobayashi, Hiroshi, Okuma, Tomotake, Kunisada, Toshiyuki, Asanuma, Kunihiro, Outani, Hedetatsu, Nishimura, Shunji, Kawashima, Hiroyuki, Akiyama, Toru, Yasuda, Taketoshi, Miwa, Shinji, Sudo, Akihiro, Ueda, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567545/ https://www.ncbi.nlm.nih.gov/pubmed/33116858 http://dx.doi.org/10.2147/CMAR.S270178 |
Ejemplares similares
-
The adverse effect of an unplanned surgical excision of foot soft tissue sarcoma
por: Nishimura, Akinobu, et al.
Publicado: (2011) -
Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study
por: Urakawa, Hiroshi, et al.
Publicado: (2020) -
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan
por: Nakamura, Tomoki, et al.
Publicado: (2020) -
Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022) -
Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?
por: Nakamura, Tomoki, et al.
Publicado: (2022)